Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Julie Christine Lauffenburger, Ph.D., Pharm.D.

Concepts (245)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medication Adherence32202421754.540 Why?
Prescription Drugs520236311.680 Why?
Inappropriate Prescribing420242121.650 Why?
Pharmaceutical Services620211411.530 Why?
Pharmacy22022911.410 Why?
Hypoglycemic Agents10202430891.350 Why?
Hypertension16202485361.330 Why?
Insurance, Pharmaceutical Services420233481.290 Why?
Chronic Disease11202193191.060 Why?
Diabetes Mellitus, Type 292023121590.880 Why?
Health Expenditures6202323620.870 Why?
Antidepressive Agents, Tricyclic120244310.780 Why?
Electronic Prescribing120211140.710 Why?
Touch Perception120211060.710 Why?
Antihypertensive Agents8202420190.690 Why?
Pharmacies220211680.680 Why?
Pharmacists420192590.670 Why?
Reinforcement, Social12018100.640 Why?
Anticoagulants6202447950.630 Why?
Gout220236210.620 Why?
Cardiovascular Agents320198420.600 Why?
Medicare12202467730.600 Why?
Nurse Practitioners120212690.580 Why?
Glycemic Index120203960.570 Why?
Patient-Centered Care2201714270.540 Why?
Uric Acid120238070.540 Why?
Warfarin3202414820.540 Why?
Cardiovascular Diseases72023155200.530 Why?
Insulin3202065880.530 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors5202332450.520 Why?
Drug Prescriptions3202416680.510 Why?
Metformin120239100.510 Why?
Complementary Therapies120204870.510 Why?
United States322024723390.510 Why?
Health Care Costs2202032390.500 Why?
Fee-for-Service Plans120206980.500 Why?
Medical Informatics120227330.500 Why?
Medication Therapy Management220171300.490 Why?
Atrial Fibrillation5202451140.490 Why?
Community Pharmacy Services22012520.490 Why?
Retrospective Studies282024806740.490 Why?
Vaccines120238350.480 Why?
Communication4202238720.470 Why?
Cost Control120176270.460 Why?
Health Services Needs and Demand1202214010.460 Why?
Humans8220247612080.460 Why?
Shock, Septic120207690.450 Why?
Diabetes Complications1202013160.440 Why?
Medicare Part D220193540.430 Why?
Female5420243925440.430 Why?
Primary Health Care6202446780.410 Why?
Social Support1202221750.400 Why?
Polypharmacy320213070.400 Why?
Male4620243606930.390 Why?
Antidepressive Agents1202428930.390 Why?
Aged3420241692880.380 Why?
Adrenal Cortex Hormones1202018780.380 Why?
Analgesics, Opioid3202338050.380 Why?
Diabetes Mellitus7202158420.380 Why?
Life Change Events120169520.370 Why?
Middle Aged3320242208530.360 Why?
Formularies as Topic12011940.360 Why?
Databases, Factual4201679660.360 Why?
Electronic Health Records4202448220.340 Why?
Prescriptions220233860.340 Why?
Self Report4202337270.340 Why?
Hyperlipidemias420187710.330 Why?
Pharmacoepidemiology120133510.330 Why?
Patient Participation2202414450.330 Why?
Patient Compliance1201926880.310 Why?
Drugs, Generic120134480.300 Why?
Gastrointestinal Hemorrhage1201511160.300 Why?
Family1201831920.290 Why?
Telephone220226240.290 Why?
Heart Failure42024117010.280 Why?
Sepsis1202025850.270 Why?
Health Behavior1201826410.270 Why?
Hepatitis C, Chronic1201410270.270 Why?
Telemedicine2202130510.260 Why?
Decision Making2202239310.260 Why?
Thrombolytic Therapy1201520550.260 Why?
Insurance Claim Review320207410.260 Why?
Internship and Residency2202458850.250 Why?
Drug Costs2202311830.250 Why?
Long-Term Care220206300.240 Why?
Blood Pressure6202384790.240 Why?
Adult2420242211190.230 Why?
Insurance, Health1201724930.230 Why?
Physicians1202245840.230 Why?
Cholinergic Antagonists120241670.210 Why?
Atherosclerosis3202334060.200 Why?
Cohort Studies92023414960.200 Why?
Administration, Oral4202440150.200 Why?
Antiviral Agents1201430480.200 Why?
Aged, 80 and over112024589520.200 Why?
Risk Assessment52024240210.190 Why?
Blood Pressure Determination220226330.190 Why?
Brain Ischemia1201530320.190 Why?
Qualitative Research2202230240.190 Why?
Patient Care220206230.190 Why?
Gout Suppressants120231770.180 Why?
Tranexamic Acid120231720.180 Why?
Antifibrinolytic Agents120232870.180 Why?
Blood Glucose3202063920.170 Why?
Electronics120213170.170 Why?
Medical Staff, Hospital120246010.170 Why?
Insurance Carriers120211550.170 Why?
Logistic Models42019132490.170 Why?
New Jersey120202950.160 Why?
Behavior Control12019470.160 Why?
Vaccination2202333690.160 Why?
Myocardial Infarction32015114760.160 Why?
Technology120212940.160 Why?
Postal Service12018960.150 Why?
Drugs, Investigational220182120.150 Why?
Benzodiazepines1202411340.150 Why?
Medicare Part B120191170.150 Why?
Public Health1201126720.150 Why?
Secondary Prevention1202414720.150 Why?
Remote Consultation120202370.150 Why?
Frail Elderly120237660.140 Why?
Policy120215060.140 Why?
Adenosine Diphosphate120184220.140 Why?
Risk Factors92023742390.140 Why?
Hypnotics and Sedatives1202411780.130 Why?
Angiotensin Receptor Antagonists1202210390.130 Why?
Minority Groups1202312010.130 Why?
Reminder Systems120183860.120 Why?
Cost Sharing120194090.120 Why?
Biotransformation120141660.120 Why?
Cross-Sectional Studies32024260710.120 Why?
Comorbidity32020105160.120 Why?
Cytochrome P-450 CYP3A120141130.120 Why?
Small-Area Analysis12014520.120 Why?
Randomized Controlled Trials as Topic22021102180.110 Why?
Drug Approval220188120.110 Why?
Follow-Up Studies42020391260.110 Why?
Drug Utilization Review120142480.110 Why?
Clinical Trials, Phase III as Topic120168580.100 Why?
Prevalence32021157210.100 Why?
Education, Pharmacy12012380.100 Why?
Angiotensin-Converting Enzyme Inhibitors2202215040.100 Why?
Referral and Consultation2202236080.100 Why?
Patient Care Planning120179010.100 Why?
Income1202018690.100 Why?
Odds Ratio1202496520.090 Why?
International Normalized Ratio120133820.090 Why?
Platelet Aggregation Inhibitors2202427460.090 Why?
Adaptation, Psychological1202126320.090 Why?
Regression Analysis2201863450.090 Why?
Treatment Failure1201626430.090 Why?
Propensity Score2201519160.090 Why?
Cross-Over Studies1201620820.090 Why?
Malawi120113000.090 Why?
Drug Interactions1201414170.080 Why?
Health Status Disparities1202118470.080 Why?
Research Design3202161800.080 Why?
Publishing120168320.080 Why?
Socioeconomic Factors2202078040.080 Why?
Sex Distribution1201322770.080 Why?
Cesarean Section1201713990.080 Why?
Comparative Effectiveness Research120137090.080 Why?
Public Policy120125570.080 Why?
Survival Analysis12020100880.070 Why?
Adrenergic beta-Antagonists1201312410.070 Why?
Registries1202482470.070 Why?
Age Distribution1201328710.070 Why?
Drug Utilization1201311880.070 Why?
Cost-Benefit Analysis1202054930.070 Why?
Influenza, Human1201815210.070 Why?
Intensive Care Units1202037440.070 Why?
Treatment Outcome42024646810.070 Why?
Prognosis22020296870.070 Why?
Decision Support Techniques1201720040.070 Why?
Health Personnel1202133370.070 Why?
Drug Monitoring120139610.070 Why?
Hypolipidemic Agents220246090.070 Why?
Chi-Square Distribution1201334180.070 Why?
Pain, Postoperative1201717410.070 Why?
Drug Therapy, Combination1201763040.070 Why?
Intention to Treat Analysis220184130.070 Why?
Young Adult42021592210.070 Why?
Bone Density Conservation Agents120137930.070 Why?
Delivery of Health Care2202253330.070 Why?
Reimbursement Mechanisms120126670.070 Why?
Focus Groups1201214130.060 Why?
Sensitivity and Specificity12020146750.060 Why?
Evidence-Based Medicine2201436910.060 Why?
Combined Modality Therapy1201785190.060 Why?
Adolescent42021882980.060 Why?
Opioid-Related Disorders1201921640.060 Why?
Sex Factors22015105530.060 Why?
Transcription Factors12024120990.060 Why?
Hospitalization12024107070.060 Why?
Osteoporosis1201316040.060 Why?
Residence Characteristics1201420920.060 Why?
Disease Progression12020135110.050 Why?
Linear Models1201358690.050 Why?
Hemoptysis120231510.050 Why?
Denmark120247700.050 Why?
Digoxin120222460.050 Why?
Time Factors22024399570.050 Why?
Habits120211470.050 Why?
Ambulatory Care1201227700.050 Why?
Administration, Inhalation1202311590.040 Why?
Longitudinal Studies12017146100.040 Why?
Glucagon-Like Peptide 1120233640.040 Why?
Age Factors32024183840.040 Why?
Pyridones120248090.040 Why?
Behavioral Sciences12018290.040 Why?
Stroke2202497210.040 Why?
Biphenyl Compounds1202210070.040 Why?
Thiazoles1202415170.030 Why?
Early Termination of Clinical Trials12016690.030 Why?
Quality of Health Care1201243200.030 Why?
Patient Acceptance of Health Care2202232000.030 Why?
Tetrazoles120229090.030 Why?
Deductibles and Coinsurance120183160.030 Why?
Drug Combinations1202220480.030 Why?
Immunization Programs120182670.030 Why?
Antineoplastic Agents12018136320.030 Why?
Evidence-Based Practice120184930.030 Why?
Pyrazoles1202420100.030 Why?
Students, Pharmacy12012170.030 Why?
Pyridines1202428720.030 Why?
Safety1201611510.020 Why?
Injections120138320.020 Why?
Obstetrics120176680.020 Why?
Health Knowledge, Attitudes, Practice1202440140.020 Why?
Professional Role120123130.020 Why?
United States Food and Drug Administration1201816620.020 Why?
Social Class1201819930.020 Why?
Faculty120123830.020 Why?
Neoplasms12018221400.020 Why?
Healthcare Disparities1202433540.020 Why?
Stroke Volume1202255210.020 Why?
Advisory Committees120127880.020 Why?
Patient Selection1201942460.020 Why?
Risk1201896160.020 Why?
Medicaid1201928130.020 Why?
Periodicals as Topic1201614630.020 Why?
Teaching1201211710.010 Why?
Exercise1201958740.010 Why?
Prospective Studies22018544350.010 Why?
Pregnancy12017298930.010 Why?
Lauffenburger's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (245)
Explore
_
Co-Authors (35)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.